BPH Global Ltd
AASX:BP8DF0.01
AUD
+0.00
(+16.67%)
ISIN
AU0000484735
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- Matthew Leonard
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Melbourne Australia
- Website
- bphglobal.com.au
- Similar Companies
- Business
- BPH Global Ltd is an Australian biotechnology and marine resources company engaged in the sourcing, cultivation, processing, commercialization, and global trading of plant- and marine-based bioactive products, functional ingredients, and traditional health formulations. The company focuses on the blue economy and biotechnology sectors, utilizing proprietary plant genetics, propagation methods, and extraction technologies to develop sustainable health, food, cosmetic, and agricultural products across the Asia-Pacific region. The company operates through integrated business divisions providing a comprehensive range of products and services, including: commercial seaweed trading and supply chain logistics, encompassing the bulk sourcing, drying, grading, warehousing, and export of marine algae species such as Caulerpa lentillifera (sea grapes or green caviar) and red seaweeds; edible bird's nest products, comprising both raw unprocessed and processed consumer-grade Traditional Chinese Medicine (TCM) products; specialized plant-based nutritional extracts and wellness supplements, including powdered green seaweed kefir functional additives and men's health formulations; industrial hemp and botanical ingredients for health and cosmetic applications; and agricultural bio-fertilizers and bio-stimulants derived from seaweed biomass. Additionally, the company conducts research and development focused on marine bioproduct innovation, including extraction processes for minerals and bioactive compounds from marine macroalgae. Headquartered in Melbourne, Australia, BPH Global Ltd was founded in 1984 and was formerly known as Stemcell United Limited before rebranding to BPH Global Ltd to reflect its expanded focus on marine biotechnology and regional commerce. The company maintains operational footprints, sourcing hubs, and commercial partnerships across Australia, Indonesia, China, Singapore, and Malaysia, operating through subsidiaries such as PT BPH Global Indonesia, Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, Foshan Gedishi Biotechnology Co Ltd, Yunnan Huafang Industrial Hemp Co Ltd, Hainan SCU Biotechnology Co Ltd, and SCU Southeast Asia Sdn Bhd. In recent developments, BPH Global Ltd has executed a strategic expansion of its Indonesian marine operations through the acquisition of the seaweed business and assets of PT Mitra Global and the commissioning of an independent processing and warehousing facility in Makassar to scale export capabilities. The company entered into a binding product sales cooperation agreement with PT Kebula Raya Bestari to optimize regional distribution and logistics, while expanding independent trading operations to serve key export markets in China and Southeast Asia. BPH Global completed the acquisition of Foshan Gedishi Biotechnology Co Ltd and renewed distribution agreements with subsidiaries of China Tobacco. To support ongoing commercialization and clinical development, the company launched collaborative research initiatives, including Project 6-7 with Gaia Mariculture to investigate mineral and trace metal extraction from seaweed, entered development agreements for seaweed-derived functional health additives, secured a commercial trade financing facility, and completed private placement capital raisings to fund processing capacity expansion and working capital.